These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22267837)

  • 1. Weighing in on heart failure: the role of SERCA2a SUMOylation.
    Schwartz RJ; Yeh ET
    Circ Res; 2012 Jan; 110(2):198-9. PubMed ID: 22267837
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure.
    Kho C; Lee A; Jeong D; Oh JG; Gorski PA; Fish K; Sanchez R; DeVita RJ; Christensen G; Dahl R; Hajjar RJ
    Nat Commun; 2015 Jun; 6():7229. PubMed ID: 26068603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoplasmic reticulum Ca-ATPase and heart failure 20 years later.
    Eisner D; Caldwell J; Trafford A
    Circ Res; 2013 Sep; 113(8):958-61. PubMed ID: 24071456
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-translational Modifications in Heart Failure: Small Changes, Big Impact.
    Lee A; Oh JG; Gorski PA; Hajjar RJ; Kho C
    Heart Lung Circ; 2016 Apr; 25(4):319-24. PubMed ID: 26795636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors controlling the activity of the SERCA2a pump in the normal and failing heart.
    Vandecaetsbeek I; Raeymaekers L; Wuytack F; Vangheluwe P
    Biofactors; 2009; 35(6):484-99. PubMed ID: 19904717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure].
    Fu ZQ; Li XY; Liu XH; Sun S; Liu T; Mi YF; Zhou SA; Ye WH; Wang QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):260-5. PubMed ID: 19099986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of sarco-endoplasmic reticulum Ca(2 +) -ATPase in the failing cardiomyocyte].
    Ikeda Y
    Clin Calcium; 2013 Apr; 23(4):535-42. PubMed ID: 23545743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
    Kawase Y; Hajjar RJ
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):554-65. PubMed ID: 18665137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Ubc9 and the intensity of SERCA2a-SUMOylation were reduced in diet-induced obese rats and partially restored by trimetazidine.
    Yao J; Shao XH; Song GY; Zhao ZY; Teng SY; Wu YJ
    J Cardiovasc Pharmacol; 2015 Jan; 65(1):47-53. PubMed ID: 25329748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
    Li XY; Hui HP; Lu XC; Guo YT
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
    Papolos A; Frishman WH
    Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA therapy for the failing heart.
    Martinez-Fernandez A
    Circ Cardiovasc Genet; 2014 Jun; 7(3):393-4. PubMed ID: 24951666
    [No Abstract]   [Full Text] [Related]  

  • 13. SERCA2a gene therapy for the prevention of sudden cardiac death: a future theranostic for heart failure?
    Shah SJ; Wasserstrom JA
    Circulation; 2012 Oct; 126(17):2047-50. PubMed ID: 23019292
    [No Abstract]   [Full Text] [Related]  

  • 14. The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA).
    Stammers AN; Susser SE; Hamm NC; Hlynsky MW; Kimber DE; Kehler DS; Duhamel TA
    Can J Physiol Pharmacol; 2015 Oct; 93(10):843-54. PubMed ID: 25730320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
    Hajjar RJ; Zsebo K; Deckelbaum L; Thompson C; Rudy J; Yaroshinsky A; Ly H; Kawase Y; Wagner K; Borow K; Jaski B; London B; Greenberg B; Pauly DF; Patten R; Starling R; Mancini D; Jessup M
    J Card Fail; 2008 Jun; 14(5):355-67. PubMed ID: 18514926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
    Kawase Y; Ly HQ; Prunier F; Lebeche D; Shi Y; Jin H; Hadri L; Yoneyama R; Hoshino K; Takewa Y; Sakata S; Peluso R; Zsebo K; Gwathmey JK; Tardif JC; Tanguay JF; Hajjar RJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1112-9. PubMed ID: 18342232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERCA2a Protein Levels Are Unaltered in Human Heart Failure.
    Ragone I; Barallobre-Barreiro J; Takov K; Theofilatos K; Yin X; Schmidt LE; Domenech N; Crespo-Leiro MG; van der Voorn SM; Vink A; van Veen TAB; Bödör C; Merkely B; Radovits T; Mayr M
    Circulation; 2023 Aug; 148(7):613-616. PubMed ID: 37579008
    [No Abstract]   [Full Text] [Related]  

  • 18. The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective.
    Hayward C; Banner NR; Morley-Smith A; Lyon AR; Harding SE
    Hum Gene Ther; 2015 May; 26(5):293-304. PubMed ID: 25914929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium handling in the failing heart and SUMO--weighing the evidence.
    McMurray JJ; Smith GL
    N Engl J Med; 2011 Nov; 365(18):1738-9. PubMed ID: 22047567
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a minipig model of chronic ischemic heart failure].
    Xin W; Lu XC; Li XY; Niu K; Cai JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):336-42. PubMed ID: 21624310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.